botulinum toxin Type A
191622-111
Phase 3 mab completed
Quick answer
botulinum toxin Type A for Pediatrics is a Phase 3 program (mab) at Allergan Pharmaceuticals International Limited with 4 ClinicalTrials.gov record(s).
Program details
- Company
- Allergan Pharmaceuticals International Limited
- Indication
- Pediatrics
- Phase
- Phase 3
- Modality
- mab
- Status
- completed